Neurocrine Biosciences Inc (NBIX) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 17.07%1,122.70 | 959.00 | 814.50 | 805.50 | 794.90 |
16.69%366.30 | 439.70 | 318.50 | - | - | |
| Selling, General, and Administrative | 16.69%366.30 | 439.70 | 318.50 | - | - |
| Costs And Expenses | 1.99%791.40 | 807.50 | 621.10 | 594.60 | 555.90 |
| Operating Income/Loss | 118.68%331.30 | 151.50 | 193.40 | 210.90 | 239.00 |
| Nonoperating Income/Loss | 544.86%-47.60 | 10.70 | 53.40 | 28.50 | 52.80 |
| Income/Loss From Continuing Operations Before Tax | 74.91%283.70 | 162.20 | 246.80 | 239.40 | 291.80 |
| Income Tax Expense/Benefit | 333.71%77.20 | 17.80 | 48.90 | 85.70 | 82.30 |
43.01%206.50 | 144.40 | 197.90 | 153.70 | 209.50 | |
| Attributable To Parent | 43.01%206.50 | 144.40 | 197.90 | 153.70 | 209.50 |
| Available To Common Stockholders, Basic | 43.01%206.50 | 144.40 | 197.90 | 153.70 | 209.50 |
| Basic Average Shares | 0.59%101.60 | 101.00 | 100.50 | 0.20 | 99.40 |
| Diluted Average Shares | 0.96%105.20 | 104.20 | 103.40 | 0.50 | 102.50 |
| Basic Earnings Per Share | 41.96%2.03 | 1.43 | 1.97 | 1.54 | 2.11 |
| Diluted Earnings Per Share | 41.01%1.96 | 1.39 | 1.91 | 1.48 | 2.04 |